Insiders Poseida Therapeutics, Inc.

Equities

PSTX

US73730P1084

Market Closed - Nasdaq Other stock markets 01:30:00 11/05/2024 am IST			5-day change	1st Jan Change
2.645 ^USD	-2.40%		-7.84%	-21.28%

02/05	Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos	MT
01/05	Malin Corp investee signs agreement with Astellas Pharma	AN

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Poseida Therapeutics Appoints Syed Rizvi as Chief Medical Officer	26/03	MT
Poseida Therapeutics, Inc Appoints Syed Rizvi as Chief Medical Officer Effective April 1, 2024	26/03	CI
Poseida Therapeutics, Inc. Announces Executive Changes	08/03	CI
Poseida Therapeutics, Inc. Announces Board Changes	10/23/10	CI
Poseida Therapeutics, Inc. Announces Chief Executive Officer Changes	10/23/10	CI
Poseida Therapeutics Names Kristin Yarema as CEO, Mark Gergen as Executive Chairman	10/23/10	MT
Poseida Therapeutics, Inc. Appoints Kristin Yarema as President, Cell Therapy	12/23/12	CI
Poseida Therapeutics, Inc. Appoints Five New Members to Its Gene Therapy Scientific Advisory Board	01/23/01	CI
Poseida Therapeutics Executive Chairman Resigns; Shares Fall After-Hours	01/23/01	MT
Poseida Therapeutics, Inc. Announces Resignation of Eric Ostertag as Executive Chairman and Retirement from the Board of Directors, Effective February 3, 2023	01/23/01	CI
Poseida Therapeutics, Inc. Announces Appointment of George M. Church as Chair of Gene Therapy Scientific Advisory Board	26/22/26	CI
Poseida Therapeutics Appoints Charles M. Baum to Board of Directors	18/22/18	CI
Matthew Spear Informs Poseida Therapeutics, Inc. of His Intent to Resign from Chief Medical Officer Position, Effective April 22, 2022	08/22/08	CI
Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy	22/22/22	CI
Poseida Therapeutics President Mark Gergen Named CEO, Wll Succeed Eric Ostertag in February	10/22/10	MT
Poseida Therapeutics, Inc. Announces Executive Changes	10/22/10	CI
Poseida Therapeutics Announces Mark Gergen as Chief Executive Officer, Effective February 1, 2022	10/22/10	CI
Poseida Therapeutics : Promotes Johanna Mylet to Finance Chief	13/21/13	MT
Poseida Therapeutics Announces Leadership Appointments	13/21/13	CI
Poseida Therapeutics Announces Leadership Appointments	13/21/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Poseida Therapeutics, Inc.

Equities

PSTX

US73730P1084

Insiders

Filters